The long-term pathological evolution of chronic hepatitis C

被引:458
作者
Yano, M
Kumada, H
Kage, M
Ikeda, K
Shimamatsu, K
Inoue, O
Hashimoto, E
Lefkowitch, JH
Ludwig, J
Okuda, K
机构
[1] CHIBA UNIV, SCH MED, DEPT MED 1, CHUO KU, CHIBA 260, JAPAN
[2] NAGASAKI CHUO NATL HOSP, INST CLIN RES, OHMURA, JAPAN
[3] TORANOMON GEN HOSP, DEPT GASTROENTEROL, TOKYO, JAPAN
[4] KURUME UNIV, SCH MED, DEPT PATHOL 1, KURUME, FUKUOKA, JAPAN
[5] TOKYO WOMENS MED COLL, INST GASTROENTEROL, TOKYO 162, JAPAN
[6] COLUMBIA UNIV, COLL PHYS & SURG, NEW YORK, NY USA
[7] MAYO CLIN, DEPT MED PATHOL, ROCHESTER, MN USA
[8] CHIBA UNIV, SCH MED, CHIBA 280, JAPAN
关键词
D O I
10.1053/jhep.1996.v23.pm0008675148
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Most patients infected with hepatitis C virus (HCV) develop chronic hepatitis. Unfortunately, the pathological evolution of this disease over time is not completely understood. We studied 70 HCV-positive patients, from whom 2 to 10 liver biopsy specimens (mean, 3.9) had been obtained during an interval of 1 to 26 years (mean, 8.8 years). Each biopsy specimen was evaluated-independently by four pathologists who each provided a numerical score for the grade of portal/periportal necroinflammation (0-4), grade of lobular necroinflammation (0-4), their sum (final grade), and the stage of fibrosis (1-4), The scores were correlated with progression of disease, if any, and transition to cirrhosis. During follow-up, 35 patients (50%) developed cirrhosis. Cirrhosis developed in all patients with a high final grade (greater than or equal to 5) of necroinflammation on initial biopsy who were followed for 10 years and in 96% of patients with an intermediate final grade (3.5-4.9) who were followed for 17 years. Only 30.4% of patients with low final grade (less than or equal to 3.4) on initial biopsy developed cirrhosis after 13 years. All patients with evidence of septal fibrosis with incomplete nodularity (stage 3.0-3.4) in the initial biopsy progressed to unequivocal cirrhosis by 10 years. The rate of progression to cirrhosis was accelerated in patients whose initial biopsies showed high-grade and -stage lesions, This study demonstrates the importance of grading and staging liver biopsy lesions in chronic hepatitis C, particularly for patients with high-grade necroinflammation, septal fibrosis, and regions of nodularity on initial biopsy who are at high risk of developing advanced cirrhosis in the ensuing decade.
引用
收藏
页码:1334 / 1340
页数:7
相关论文
共 50 条
  • [31] Long-term cohort study of chronic hepatitis C according to interferon efficacy
    Maruoka, Daisuke
    Imazeki, Fumio
    Arai, Makoto
    Kanda, Tatsuo
    Fujiwara, Keiichi
    Yokosuka, Osamu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) : 291 - 299
  • [32] Long-Term Impact of Antiviral Therapy in the Natural History of Chronic Hepatitis C
    Cordero-Ruiz, Patricia
    Carmona-Soria, Isabel
    Caunedo-Alvarez, Angel
    Herrerias, Juan M.
    Vilches-Arenas, Angel
    GASTROENTEROLOGY, 2014, 146 (05) : S256 - S256
  • [33] Analysis of long-term follow-up and examination of pathological liver tissue in chronic hepatitis E
    Liu, Li
    Liu, Yunhua
    Du, Yingrong
    Liu, Chunyun
    Li, Weikun
    Li, Huimin
    Jia, Ting
    Chang, Lixian
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (06) : 684 - 686
  • [34] LONG-TERM EVOLUTION OF CHRONIC RELAPSING PANCREATITIS
    VANTINI, I
    PIUBELLO, W
    TALAMINI, G
    MICCIOLO, R
    BENINI, P
    BENINI, L
    VAONA, B
    PEDERZOLI, P
    CAVALLINI, G
    SCURO, LA
    GASTROENTEROLOGY, 1982, 82 (05) : 1204 - 1204
  • [35] LONG-TERM EVOLUTION OF CHRONIC RELAPSING PANCREATITIS
    VANTINI, I
    PIUBELLO, W
    TALAMINI, G
    MICCIOLO, R
    BENINI, P
    BENINI, L
    VAONA, B
    PEDERSOLI, P
    CAVALLINI, G
    SCURO, LA
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1983, 15 (02): : 158 - 158
  • [36] HEPATITIS-C VIRUS MARKERS IN PATIENTS WITH LONG-TERM BIOCHEMICAL AND HISTOLOGICAL REMISSION OF CHRONIC HEPATITIS
    SARACCO, G
    ABATE, ML
    BALDI, M
    CALVO, PL
    MANZINI, P
    BRUNETTO, MR
    OLIVERI, F
    KUO, G
    CHIEN, D
    HOUGHTON, M
    VERME, G
    RIZZETTO, M
    BONINO, F
    LIVER, 1994, 14 (02): : 65 - 70
  • [37] Entecavir for the long-term treatment of chronic hepatitis B
    Gonzalez, Stevan A.
    Keeffe, Emmet B.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (09) : 1053 - 1062
  • [38] Long-term treatment with lamivudine for chronic hepatitis B
    Zoulim, F
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (12): : 1153 - 1154
  • [39] CHRONIC HEPATITIS AFTER LONG-TERM ADMINISTRATION OF PAPAVERINE
    POUPON, R
    LONGCHAL, C
    DARNIS, F
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1978, 2 (03): : 305 - 308
  • [40] Long-term therapy of chronic hepatitis B with lamivudine
    Lu, DTY
    Khokhar, MF
    Doo, E
    Ghany, MG
    Herion, D
    Park, Y
    Kleiner, DE
    Schmid, P
    Condreay, LD
    Gauthier, J
    Kuhns, MC
    Liang, TJ
    Hoofnagle, JH
    HEPATOLOGY, 2000, 32 (04) : 828 - 834